GRANULES INDIA LTD.-$ - 532482 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Audio recording of the Earnings Conference call for Q4 and for the financial year 2021-2219-05-2022
19-05-2022
Earnings Call for Q4FY22 of Granules India
Conference Call with Granules India Management and Analysts on Q4FY22 Performance and Outlook. Listen to the full earnings transcript.19-05-2022
Q4FY22 Quarterly Result Announced for Granules India Ltd.
Pharmaceuticals firm Granules India declares Q4FY22 result: Granules India reports Income from operations at INR 1,030 Cr up 29% YoY, EBITDA at INR 193 Cr, EBITDA Margin at 19%; PAT at INR 111 Cr. The Board of Directors have recommended final dividend of 75 paise per equity share of Re.1/- each in addition to interim dividend of 75 paise per equity share of Re.1/- each paid during the year. Revenue for Q4FY22 stood at INR 1,030Crs, growth of 29% YoY across all geographies and segments. Revenue share from Europe increased to 21.5% when compared to 14.5% YoY. Increase in Revenue, EBITDA and PAT in Q4FY22 compared to Q3FY22, despite adverse business condition arising out of supply constraints of Para Amino Phenol (PAP), other input price cost increase and logistic cost increase. Revenue share of non-core molecules stood at 19% on a full year basis versus 16% in the previous year, in line with our long-term strategy During the quarter we filed one ANDA, two US DMF, and received two ANDA approvals. Commenting on the results, Dr Krishna Prasad Chigurupati, Chairman & Managing Director of Granules India Limited said, “FY 22 has been a challenging year for the industry in the face of adverse external environment with headwinds around the availability and price for Raw Materials, Solvents, Catalysts, uncertainties arising out of Ukraine-Russia conflict as well as reemergence of Covid cases in China. The global supply chain and logistics continue to remain under duress. In face of these challenges, Granules has demonstrated great resilience and I am happy with the performance of the Company. While we strive for continued improvement in our financial performance in the short term, we are working on long term strategy for making ourselves self-sustainable and overcome most of the challenges that we are facing now. We are now embarking on a new journey to reimagine our business model and transform Granules to an Innovative, science & technology driven organization, with responsible sustainable operations.” Result PDF19-05-2022
GRANULES INDIA LTD.-$ - 532482 - Announcement under Regulation 30 (LODR)-Investor Presentation
Granules India Limited has informed the Exchange about Investor Presentation for Q4 and FY22 Earnings.18-05-2022
GRANULES INDIA LTD.-$ - 532482 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Granules India reports Income from operations at INR 1,030 Cr up 29% YoY, EBITDA at INR 193 Cr, EBITDA Margin at 19%; PAT at INR 111 Cr.18-05-2022
GRANULES INDIA LTD.-$ - 532482 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Granules India reports Income from operations at INR 1,030 Cr up 29% YoY, EBITDA at INR 193 Cr, EBITDA Margin at 19%; PAT at INR 111 Cr.18-05-2022
GRANULES INDIA LTD.-$ - 532482 - Audited Financial Results For The Fourth Quarter And Financial Year Ended On March 31, 2022
Audited Financial Results for the Fourth Quarter and Financial Year ended on March 31, 202218-05-2022
GRANULES INDIA LTD.-$ - 532482 - Board recommends Final Dividend
Granules India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 18, 2022, inter alia, has recommended to the members, a final dividend of 75 paise per share of the face value of Re. 1/- each for the financial year 2021-22 representing 75% of the paid-up capital in addition to the interim dividend of 75 paise per share paid during the year.18-05-2022
GRANULES INDIA LTD.-$ - 532482 - Board Meeting Outcome for Outcome Of The Board Meeting Dated 18 May 2022.
Outcome of the Board meeting dated 18 May 2022.18-05-2022